Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/3746
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dale, R. | en |
dc.contributor.author | Merheb, V. | en |
dc.contributor.author | Nosadini, M. | en |
dc.contributor.author | Fung, V. | en |
dc.contributor.author | Brilot, F. | en |
dc.contributor.author | Ramanathan, S. | en |
dc.contributor.author | Prelog, K. | en |
dc.contributor.author | Barnes, E. | en |
dc.contributor.author | Tantsis, E. | en |
dc.contributor.author | Reddel, S. | en |
dc.contributor.author | Henderson, A. | en |
dc.contributor.author | Vucic, O. | en |
dc.contributor.author | Gorman, M. | en |
dc.contributor.author | Benson, L. | en |
dc.contributor.author | Alper, G. | en |
dc.contributor.author | Riney, C. | en |
dc.contributor.author | Barnett, M. | en |
dc.contributor.author | Parratt, J. | en |
dc.contributor.author | Hardy, T. | en |
dc.contributor.author | Leventer, R. | en |
dc.date.accessioned | 2022-11-07T23:45:41Z | - |
dc.date.available | 2022-11-07T23:45:41Z | - |
dc.date.issued | 2016 | en |
dc.identifier.citation | 86, (16), 2016 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/3746 | - |
dc.description.abstract | Objective: We performed clinical and radiological characterisation of first episode optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated ON(MOG-ON), aquaporin-4 antibody-associated ON(AQP4-ON), and multiple sclerosis(MS-ON). We hypothesised there would be specific radiological predictors depending on the cause of ON. Background: Early recognition of the etiology of ON affects treatment decisions and prognosis. Design/Methods: We performed a flow cytometry cell-based assay using live HEK293 cells expressing full-length human MOG to test the serum of 23 adults with AQP4 antibody-negative neuromyelitis optica spectrum disorders. Blinded neuroradiological assessment was subsequently performed on magnetic resonance imaging of fifty patients (mean age 24 years, range 3-58, 41 females) with a first episode of ON, including MOG-ON (n=19), AQP4-ON (n=11), MS-ON (n=13), and unclassified ON (n=7). Results: MOG antibodies were detected in 9/23 patients, all of whom had bilateral ON. MOG-ON patients were more likely to have a relapsing course and be steroid responsive. Bilateral involvement was more common in MOG-ON and AQP4-ON than MS-ON (84[percnt] v.82[percnt] v.23[percnt]), optic nerve head swelling was more common in MOG-ON (53[percnt] v.9[percnt] v.0[percnt]), chiasmal involvement was more common in AQP4-ON (5[percnt] v.64[percnt] v.15[percnt]), and bilateral optic tract involvement was more common in AQP4-ON (0[percnt] v.45[percnt] v.0[percnt]). Retrobulbar optic nerve involvement was more common in MOG-ON, whereas intracranial optic nerve involvement was more common in AQP4-ON. MOG-ON and AQP4-ON had longer lesion lengths and lesion extent scores than MS-ON. AQP4-ON more frequently had severe and sustained visual impairment. Conclusions: MOG antibodies are associated with a bilateral ON phenotype and are steroid responsive. MOG and AQP4-ON are frequently bilateral and longitudinally extensive, compared with MS-ON. MOG-ON tends to involve the anterior optic pathway whereas AQP4-ON tends to involve the posterior optic pathway. These radiological predictors may expedite diagnosis at the first presentation of ON, with therapeutic and prognostic implications.L722502922016-04-27 <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Neurology | en |
dc.title | Myelin oligodendrocyte glycoprotein antibodies are associated with bilateral and recurrent optic neuritis and have a distinct radiological profile to multiple sclerosis or aquaporin-4 antibody-associated optic neuritis | en |
dc.type | Article | en |
dc.subject.keywords | etiology | en |
dc.subject.keywords | antibodymyelin oligodendrocyte glycoprotein | en |
dc.subject.keywords | aquaporin 4 antibody | en |
dc.subject.keywords | steroid | en |
dc.subject.keywords | nitrogen 13 | en |
dc.subject.keywords | optic neuritis | en |
dc.subject.keywords | American | en |
dc.subject.keywords | multiple sclerosis | en |
dc.subject.keywords | neurology | en |
dc.subject.keywords | human | en |
dc.subject.keywords | patient | en |
dc.subject.keywords | optic nerve | en |
dc.subject.keywords | visual system | en |
dc.subject.keywords | myelooptic neuropathy | en |
dc.subject.keywords | adult | en |
dc.subject.keywords | serum | en |
dc.subject.keywords | assay | en |
dc.subject.keywords | diagnosis | en |
dc.subject.keywords | phenotype | en |
dc.subject.keywords | flow cytometry | en |
dc.subject.keywords | prognosis | en |
dc.subject.keywords | optic tract | en |
dc.subject.keywords | swelling | en |
dc.subject.keywords | nuclear magnetic resonance imaging | en |
dc.subject.keywords | retrobulbar drug administration | en |
dc.subject.keywords | visual impairment | en |
dc.subject.keywords | diseases | en |
dc.subject.keywords | female | en |
dc.relation.url | https://www.embase.com/search/results?subaction=viewrecord&id=L72250292&from=export | en |
dc.identifier.risid | 2225 | en |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
Appears in Sites: | Children's Health Queensland Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.